Skip to content

Search

Search managers or tickers

Engaged Capital

Q1 2018 13F · by Glenn Welling, CIO

As of
Mar 31, 2018
Filed
May 15, 2018
US stock
$737M · prev $788M
Positions
15 · prev 15
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves12 since the prior filing

The book

Very concentrated · behaves like 3 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Low turnover · 19% a year, about 5.4 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions80% of US stock

  1. HAIN Hain Celestial Group Inc added−4.50 pp added−4.5051.2%
  2. UPBD Upbound Group, Inc. held held10.5%
  3. STKL SunOpta, Inc. held held6.5%
  4. APOG Apogee Enterprises Inc added+3.69 pp added+3.695.9%
  5. FNSR Finisar Corp new+5.45 pp new+5.455.5%

Positions15 in this filing · 2 exited

HAINHain Celestial Group Inc51.20%11,761,242$377Madded+14%−4.50 pp5 q
UPBDUpbound Group, Inc.10.52%8,983,609$78Mheld—6 q
STKLSunOpta, Inc.6.51%6,756,907$48Mheld—8 q
APOGApogee Enterprises Inc5.88%998,934$43Madded×2.6+3.69 pp2 q
FNSRFinisar Corp5.45%2,538,126$40Mnew+5.45 ppnew
TIVOTivo Inc4.64%2,525,000$34Mheld—7 q
BHEBenchmark Electronics4.43%1,092,710$33Madded+15%+0.92 pp13 q
unresolvedJamba Inc3.30%2,834,002$24Mheld—16 q
CLSCelestica, Inc.2.32%1,652,439$17Mtrimmed−9%−0.10 pp3 q
MXMagnachip Semiconductor Corp.1.54%1,181,225$11Mtrimmed−20%−0.33 pp12 q
PETXAratana Therapeutics, Inc.1.20%2,000,000$9Mnew+1.20 ppnew
VYXNCR Voyix Corporation1.03%241,154$8Mtrimmed−31%−0.49 pp3 q
BWBabcock & Wilcox Enterprises, Inc.0.81%1,358,325$6Mtrimmed−31%−0.61 pp2 q
CCRNCross Ctry. Healthcare Inc.0.74%491,669$5Mheld—4 q
IWMiShares Russell 2000 ETF0.43%21,000$3Mtrimmed−17%−0.06 pp9 q
MEDMedifast, Inc.—−264,549—exited−2.34 pp—
IMAXImax Corp—−185,814—exited−0.55 pp—

Source

Form
13F-HR
Reading
0 defects · 1 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet